Monimus Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Sell
329,052
-156,565
-32% -$1.55M 0.75% 44
2026
Q1
$4.72M Buy
485,617
+231,495
+91% +$2.12M 1.31% 33
2025
Q4
$2.43M Sell
254,122
-3,934
-2% -$40K 1.6% 25
2025
Q3
$2.52M Buy
258,056
+51,581
+25% +$396K 1.55% 25
2025
Q2
$1.25M Buy
+206,475
New +$1.55M 0.91% 36

Other funds holding PRTA

Monimus Capital Management's PRTA Position: Q2 2026 in Review

Monimus Capital Management reduced its Prothena Corp (PRTA) stake by 32% in Q2 2026, selling an estimated $1.55M and leaving 329,052 shares worth $3.22M. The position accounts for 0.75% of the portfolio, ranked #44.

Monimus Capital Management first reported a position in PRTA in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.72M in Q1 2026. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Monimus Capital Management held 329,052 shares of Prothena Corp worth $3.22M as of Q2 2026.
  • Monimus Capital Management sold 156,565 Prothena Corp shares in Q2 2026, an estimated $1.55M.
  • Prothena Corp made up 0.75% of Monimus Capital Management's portfolio in Q2 2026, its #44 holding.
  • Monimus Capital Management first reported a position in Prothena Corp in Q2 2025 and has held it in 5 quarters since.
  • Monimus Capital Management's Prothena Corp position peaked at $4.72M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Monimus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.